C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2729521
The invention provides an in vitro method for predicting clinical outcome of a patient affected with a non-small cell lung carcinoma (NSCLC), which method comprises determining the expression level of at least 8 genes in a biological sample of said patient.
La présente invention concerne un procédé in vitro destiné à prédire le résultat clinique d'un patient atteint d'un carcinome bronchique à grandes cellules (NSCLC), lequel procédé comprend l'étape consistant à déterminer le niveau d'expression d'au moins 8 gènes dans un échantillon biologique dudit patient.
Broet Philippe
Camilleri-Broet Sophie
Miller Lance
Tan Patrick
Assistance Publique - Hopitaux de Paris
Fetherstonhaugh & Co.
LandOfFree
A method for predicting clinical outcome of patients with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A method for predicting clinical outcome of patients with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method for predicting clinical outcome of patients with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1925915